These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9632039)

  • 41. Risperidone for exclusively negative symptoms.
    Lane HY; Liu CC; Chang WH
    Am J Psychiatry; 1999 Feb; 156(2):335. PubMed ID: 9989576
    [No Abstract]   [Full Text] [Related]  

  • 42. Fluoxetine-clomipramine interaction.
    Sternbach H
    J Clin Psychiatry; 1995 Apr; 56(4):171-2. PubMed ID: 7713858
    [No Abstract]   [Full Text] [Related]  

  • 43. Priapism associated with polypharmacy.
    Seger A; Lamberti JS
    J Clin Psychiatry; 2001 Feb; 62(2):128. PubMed ID: 11247100
    [No Abstract]   [Full Text] [Related]  

  • 44. [Obsessive-compulsive symptoms treatment in: schizophrenia].
    Faucher S; Dardennes R; Ghaëm O; Guelfi JD
    Can J Psychiatry; 2005 Jun; 50(7):423-8. PubMed ID: 16086540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gynecomastia with risperidone-fluoxetine combination.
    Benazzi F
    Pharmacopsychiatry; 1999 Jan; 32(1):41. PubMed ID: 10071182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A possible tetracycline-risperidone-sertraline interaction in an adolescent.
    Steele M; Couturier J
    Can J Clin Pharmacol; 1999; 6(1):15-7. PubMed ID: 10465861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Second-generation antipsychotics for obsessive compulsive disorder.
    Komossa K; Depping AM; Meyer M; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008141. PubMed ID: 21154394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lingual lesions with orally disintegrating risperidone.
    Dowling NM; Megna JL; Burgdorf A; Yashaswi V
    Am J Psychiatry; 2006 Oct; 163(10):1841-2. PubMed ID: 17012704
    [No Abstract]   [Full Text] [Related]  

  • 49. Remission of drug-induced hepatitis after switching from risperidone to paliperidone.
    Paulzen M; Orfanos S; Gründer G
    Am J Psychiatry; 2010 Mar; 167(3):351-2. PubMed ID: 20194492
    [No Abstract]   [Full Text] [Related]  

  • 50. Obsessive-compulsive disorder, fluoxetine, and buspirone.
    Sternlicht HC
    Am J Psychiatry; 1993 Mar; 150(3):526. PubMed ID: 8434680
    [No Abstract]   [Full Text] [Related]  

  • 51. Aripiprazole augmentation in clozapine-associated obsessive-compulsive symptoms.
    Villari V; Frieri T; Fagiolini A
    J Clin Psychopharmacol; 2011 Jun; 31(3):375-6. PubMed ID: 21532362
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-term safety of risperidone.
    Davidson M
    J Clin Psychiatry; 2001; 62 Suppl 21():26-8. PubMed ID: 11584985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Separation anxiety in children and adolescents treated with risperidone.
    Hanna GL; Fluent TE; Fischer DJ
    J Child Adolesc Psychopharmacol; 1999; 9(4):277-83. PubMed ID: 10630458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of obsessive-compulsive symptoms in schizophrenia with a neuroleptic-selective serotonin reuptake inhibitor combination: two case reports.
    Sewell DD; Lopez WM; Paulsen J; Gilbert P
    J Nerv Ment Dis; 1994 Dec; 182(12):725-7. PubMed ID: 7989921
    [No Abstract]   [Full Text] [Related]  

  • 55. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.
    Tollefson GD; Birkett M; Koran L; Genduso L
    J Clin Psychiatry; 1994 Oct; 55 Suppl():69-76; discussion 77-8. PubMed ID: 7961535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
    Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H
    Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
    [No Abstract]   [Full Text] [Related]  

  • 57. Obsessive-compulsive symptoms during treatment with clozapine in a patient with schizophrenia.
    Cheung EF
    Aust N Z J Psychiatry; 2001 Oct; 35(5):695-6. PubMed ID: 11551293
    [No Abstract]   [Full Text] [Related]  

  • 58. Limitations in discerning the effects of risperidone and its 9-hydroxy metabolite on prolactin levels in a small study of patients with schizophrenia.
    Pandina GJ; Canuso CM; Youssef E; Kujawa M; Mahmoud R
    Hum Psychopharmacol; 2007 Jul; 22(5):326-7; author reply 328. PubMed ID: 17599334
    [No Abstract]   [Full Text] [Related]  

  • 59. Worsening of obsessive-compulsive symptoms following treatment with olanzapine.
    Morrison D; Clark D; Goldfarb E; McCoy L
    Am J Psychiatry; 1998 Jun; 155(6):855. PubMed ID: 9619164
    [No Abstract]   [Full Text] [Related]  

  • 60. Reduced short-term obsessive-compulsive symptoms in schizophrenic patients treated with risperidone: a single-blind prospective study.
    Veznedaroglu B; Ercan ES; Kayahan B; Varan A; Bayraktar E
    Hum Psychopharmacol; 2003 Dec; 18(8):635-40. PubMed ID: 14696023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.